[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

OA06606A - Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée. - Google Patents

Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée.

Info

Publication number
OA06606A
OA06606A OA57119A OA57119A OA06606A OA 06606 A OA06606 A OA 06606A OA 57119 A OA57119 A OA 57119A OA 57119 A OA57119 A OA 57119A OA 06606 A OA06606 A OA 06606A
Authority
OA
OAPI
Prior art keywords
new derivatives
aminopropanesulfonic acid
membrane activity
enhanced membrane
enhanced
Prior art date
Application number
OA57119A
Other languages
English (en)
Inventor
Jean Pierre Durlach
Original Assignee
Meram Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meram Lab filed Critical Meram Lab
Publication of OA06606A publication Critical patent/OA06606A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA57119A 1979-05-23 1980-05-23 Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée. OA06606A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7913207A FR2457281A1 (fr) 1979-05-23 1979-05-23 Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee

Publications (1)

Publication Number Publication Date
OA06606A true OA06606A (fr) 1981-08-31

Family

ID=9225819

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57119A OA06606A (fr) 1979-05-23 1980-05-23 Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée.

Country Status (18)

Country Link
US (1) US4355043A (fr)
JP (2) JPS5625146A (fr)
AT (1) AT372371B (fr)
AU (1) AU535785B2 (fr)
BE (1) BE883468A (fr)
CA (1) CA1152100A (fr)
CH (1) CH647757A5 (fr)
DE (2) DE19675017I2 (fr)
ES (1) ES8101042A1 (fr)
FR (1) FR2457281A1 (fr)
GB (1) GB2051789B (fr)
GR (1) GR68547B (fr)
IT (1) IT1130455B (fr)
MA (1) MA18855A1 (fr)
MX (1) MX9203363A (fr)
NL (2) NL191789C (fr)
OA (1) OA06606A (fr)
ZA (1) ZA803051B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193197B (en) * 1984-02-03 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Preparatives regulating the growth of plants containing as reagent derivatives of n-substituated amin-prophansulphonic acid and process for production of the reagent
JPH0725771B2 (ja) * 1992-06-18 1995-03-22 財団法人生産開発科学研究所 ２−アミノエタンスルホン酸亜鉛錯化合物
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
AU765522B2 (en) * 1998-01-13 2003-09-18 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US5952389A (en) * 1998-01-13 1999-09-14 Synchroneuron Methods of treating tardive dyskinesia and other movement disorders
US6294583B1 (en) * 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US6391922B1 (en) 1998-01-13 2002-05-21 Synchroneuron, Llc Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
PT1051393E (pt) * 1998-01-27 2004-02-27 Merck Sante Sas Novos derivados de acidos aminoalcano sulfonico fosfonicos e fosfinicos sua preparacao e sua utilizacao como medicamentos
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
JP4726304B2 (ja) * 1999-04-28 2011-07-20 ベルス ヘルス （インターナショナル） リミティッド アミロイドーシスを治療するための組成物および方法
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20060183800A1 (en) * 2004-11-12 2006-08-17 Xianqi Kong Methods and fluorinated compositions for treating amyloid-related diseases
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム （インターナショナル） リミテッド Ｃｎｓおよびアミロイド関連疾患治療のための化合物
AU2005326962A1 (en) * 2004-12-22 2006-08-17 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
ATE481094T1 (de) * 2005-12-22 2010-10-15 Kiacta Sarl Behandlung von diabetischer nephropathie
BRPI0717794B8 (pt) 2006-10-12 2021-05-25 Bellus Health International Ltd composto e composição farmacêutica de ácido 3-amino-1-propanosulfônico
MX2009006768A (es) * 2006-12-22 2009-08-31 Bellus Health Int Ltd Metodos, compuestos, y composiciones para tratar trastornos metabolicos y diabetes.
KR100877134B1 (ko) * 2007-05-03 2009-01-09 주식회사 엔지켐 아캄프로세이트 칼슘의 제조방법
EP2217564A1 (fr) * 2007-09-07 2010-08-18 XenoPort, Inc. Promédicaments de libération de cyclisation d'ester de néopentyle sulfonyle d'ester d'acide pantoïque complexe d'acamprosate, leurs compositions et procédés d'utilisation
WO2009033079A1 (fr) * 2007-09-07 2009-03-12 Xenoport, Inc. Promédicaments de libération de cyclisation d'ester de néopentyle sulfonyle d'ester d'acide pantoïque masqués extérieurement, leurs compositions et procédés d'utilisation
TW200932734A (en) * 2007-10-15 2009-08-01 Xenoport Inc Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
CN101492400B (zh) * 2008-01-22 2014-03-12 北京华禧联合科技发展有限公司 一种高纯度阿坎酸钙的制备方法
DE102008048791A1 (de) 2008-09-24 2010-03-25 Merck Patent Gmbh Neue Kristallform von Calcium-3-Acetylaminopropan-1-sulfonat
IT1392327B1 (it) * 2008-09-26 2012-02-28 Laboratorio Chimico Int Spa Nuova forma polimorfa del calcio acamprosato
CN104478766A (zh) * 2014-12-25 2015-04-01 北京华禧联合科技发展有限公司 一种制备高纯度乙酰基高牛磺酸的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3039916A (en) * 1961-03-27 1962-06-19 West Laboratories Inc Anionic iodine complexes
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
JPS5418714B2 (fr) * 1974-10-08 1979-07-10
FR2321285A1 (fr) * 1975-08-18 1977-03-18 Stanley Drug Products Inc Agents antifibrinolytiques
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
US4233229A (en) * 1978-01-03 1980-11-11 Gaf Corporation Preparation of salt-free N-acyl taurines

Also Published As

Publication number Publication date
DE19675017I2 (de) 2001-04-26
NL8002997A (nl) 1980-11-25
DE3019350A1 (de) 1980-12-04
MX9203363A (es) 1992-07-01
CH647757A5 (fr) 1985-02-15
AT372371B (de) 1983-09-26
MA18855A1 (fr) 1980-12-31
ES491787A0 (es) 1980-12-16
JPH0317825B2 (fr) 1991-03-11
JPH0524135B2 (fr) 1993-04-06
NL191789C (nl) 1996-08-02
CA1152100A (fr) 1983-08-16
IT8067807A0 (it) 1980-05-22
DE3019350C2 (fr) 1989-11-30
FR2457281B1 (fr) 1983-10-07
GB2051789B (en) 1983-04-27
IT1130455B (it) 1986-06-11
ZA803051B (en) 1981-06-24
AU5869780A (en) 1980-11-27
ES8101042A1 (es) 1980-12-16
JPS5625146A (en) 1981-03-10
NL970003I1 (nl) 1997-04-01
AU535785B2 (en) 1984-04-05
JPH03148219A (ja) 1991-06-25
ATA274580A (de) 1983-02-15
GB2051789A (en) 1981-01-21
US4355043A (en) 1982-10-19
NL970003I2 (nl) 1997-08-01
FR2457281A1 (fr) 1980-12-19
NL191789B (nl) 1996-04-01
BE883468A (fr) 1980-11-24
GR68547B (fr) 1982-01-18

Similar Documents

Publication Publication Date Title
OA06606A (fr) Nouveaux dérivés de l'acide 3-aminopropanesulfonique ayant une activité membranaire renforcée.
BE851306A (fr) Nouveaux derives de l'acide 3-quinoleine carboxylique
BE860976A (fr) Solution stable contenant un acide percarboxylique
BE863429A (fr) Derives de l'acide quinoleine-carboxylique
OA05964A (fr) Dérivés de l, l-dioxyde d'acide pénicillanique.
OA05593A (fr) Nouveaux dérivés d'acide 4,5-dichlorimidazole-2- carboxylique, leur procédé de préparation et leur application comme pesticides.
BE868287A (fr) Nouveaux derives de l'acide amidinopenicillanique
BE822986A (fr) Nouveaux esters de pyrimidine d'acide thionothiolphosphorique
MA18782A1 (fr) Purification de l'acide phosphorique .
BE859846A (fr) Nouveaux derives d'acide alpha-thio-alcanoique
BE864321A (fr) Derives d'acide oxazolinoazetidinylbutyrique
FR2365341A1 (fr) Derives de l'acide l-(phenyl-3 amino-2 propionyloxy)-2 acetique
BE848023A (fr) Nouveaux derives de l'acide phosphorique,
BE810652A (fr) Purification de l'acide phosphorique
BE852313A (fr) Nouveaux derives d'acide 4,5-dichlorimidazole-2-carboxylique
IT1087977B (it) Purificazione dell'acido fosforico.
BE852172A (fr) Nouveaux derives de l'acide pyridil-phosphorique
FR2377406A1 (fr) Composes de tetrathiapentalene et de tetraselenapentalene
PT68159A (fr) Procede de preparation de nouveaux derives de l'acide piperazinecarbodithioique
FR2352818A1 (fr) Nouveaux derives de l'acide 6'-amino-spiro(cycloalkane-1,2'-penam)-3'-carboxylique
BE866900A (fr) Derives de l'acide 2-trichloromethyl-4-nitrobenzenesulfenique
BE862267A (fr) Purification de l'acide phosphorique
BE823372A (fr) Nouveaux derives de l'acide isonicotinique
BE847493A (fr) Preparation de catalyseurs d'ammonoxydation,
BE819330A (fr) Mono-et diesters de l'acide 2,5-dihydroxy-benzenesulfonique